Chenglong Li
- Molecular Biology top 2%
- Oncology top 1%
- Cancer Research top 2%
- Immunology top 5%
- Organic Chemistry top 5%
- Co-authors
- Jiayuh LinPui‐Kai LiJames R. FuchsLi LinRyan E. PavloviczSarah BallStephanie DeangelisHuameng Li
- Topics
- Cytokine Signaling Pathways and Interactions (48 papers)Cancer-related gene regulation (16 papers)Protein Tyrosine Phosphatases (14 papers)
- Cited by
- Molecular MedicineOncologyToxicology
- Journals
- Journal of the American Chemical SocietyJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- United StatesChinaPoland
In The Last Decade
Chenglong Li
169 papers receiving 6.1k citations
Peers
Comparison fields: 5 of 148
- Molecular Biology 3.6k
- Oncology 1.9k
- Cancer Research 1.0k
- Immunology 839
- Organic Chemistry 673
Countries citing papers authored by Chenglong Li
This map shows the geographic impact of Chenglong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenglong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenglong Li more than expected).
Fields of papers citing papers by Chenglong Li
This network shows the impact of papers produced by Chenglong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenglong Li. The network helps show where Chenglong Li may publish in the future.
Co-authorship network of co-authors of Chenglong Li
This figure shows the co-authorship network connecting the top 25 collaborators of Chenglong Li. A scholar is included among the top collaborators of Chenglong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenglong Li. Chenglong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 15 | |
| 8 | 3 | |
| 9 | 23 | |
| 10 | 28 | |
| 11 | 47 | |
| 12 | 1 | |
| 13 | 13 | |
| 14 | 41 | |
| 15 | 55 | |
| 16 | 31 | |
| 17 | 145 | |
| 18 | 79 | |
| 19 | 54 | |
| 20 | 197 |
About Chenglong Li
Chenglong Li is a scholar working on Oncology, Toxicology and Molecular Medicine, having authored 173 papers that have together received 6.1k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (48 papers), Cancer-related gene regulation (16 papers) and Protein Tyrosine Phosphatases (14 papers). The work is most often cited by research in Molecular Medicine (491 citations), Oncology (1.9k citations) and Toxicology (238 citations). Chenglong Li has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Jiayuh Lin, Pui‐Kai Li, James R. Fuchs, Li Lin, Ryan E. Pavlovicz, Sarah Ball, Stephanie Deangelis, Huameng Li, David Jou and Bulbul Pandit. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.